clopenthixol has been researched along with Neuroleptic Malignant Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackman, G; Cermolacce, M; Korchia, T; Richieri, R | 1 |
| Shetty, S; Vize, C | 1 |
| Henderson, T | 1 |
| Alkin, T; Demopulos, CM; Ozerdem, A; Sagduyu, K; Yildiz, A | 1 |
| Bildik, T; Ercan, ES; Erermis, S; Gockay, A; Karasoy, H; Tamar, M | 1 |
| Aksoy, A; Ates, O; Deniz, O; Gundogdu, OL; Varoglu, AO | 1 |
| Hamlin, GW; Ormerod, LP; Parry, AK; Saleem, PT | 1 |
| Drumer, D; Gheorghiu, S; Knobler, HY | 1 |
| Forget, PP; Rubio-Gozalbo, ME; Spaapen, LJ; van Waardenburg, DA; Verrips, A; Vroomen, PC | 1 |
| de Boer, C; Gaete, HP | 1 |
| Burrell, MF; Cashman, M; Fewster, C; Szabadi, E | 1 |
| Kemperman, CJ; van den Hoofdakker, RH | 1 |
| Kemperman, CJ | 1 |
| Sullivan, CF | 1 |
14 other study(ies) available for clopenthixol and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose.
Topics: Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dehydration; Drug Overdose; Female; Fluid Therapy; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Neuromuscular Agents; Psychotic Disorders | 2018 |
An unusual case of neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Clozapine; Dibenzothiazepines; Humans; Male; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Treatment Outcome | 2010 |
Neuroleptic malignant syndrome in adolescents: four probable cases in the Western Cape.
Topics: Adolescent; Antipsychotic Agents; Clopenthixol; Humans; Male; Methamphetamine; Neuroleptic Malignant Syndrome; Polypharmacy; Risk Factors; Sex Factors; South Africa; Substance-Related Disorders | 2011 |
Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
Topics: Acute-Phase Proteins; Adult; Antipsychotic Agents; Bromocriptine; Clopenthixol; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Thioridazine | 2003 |
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Topics: Adolescent; Anti-Anxiety Agents; Antidotes; Antipsychotic Agents; Bromocriptine; Clopenthixol; Delayed-Action Preparations; Diazepam; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lithium Compounds; Lorazepam; Neuroleptic Malignant Syndrome; Treatment Outcome | 2007 |
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man.
Topics: Antipsychotic Agents; Clopenthixol; Creatine Kinase; Delayed-Action Preparations; Diagnosis, Differential; Fatal Outcome; Fever of Unknown Origin; Humans; Hyperglycemia; Injections, Intramuscular; Male; Middle Aged; Myocardial Infarction; Neuroleptic Malignant Syndrome; Schizophrenia; Shock, Cardiogenic | 2009 |
Recurrent sinus arrest in association with neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Cardiac Pacing, Artificial; Catatonia; Chlorpromazine; Clopenthixol; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Heart Arrest; Humans; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizophrenia | 1994 |
Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chlorprothixene; Clopenthixol; Female; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence | 1999 |
Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Antipsychotic Agents; Child; Child Behavior Disorders; Clopenthixol; Humans; Male; Neuroleptic Malignant Syndrome; Simvastatin | 2001 |
Neuroleptic malignant syndrome and diabetic keto-acidosis.
Topics: Adult; Chlorpromazine; Clopenthixol; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1992 |
Clozapine-treated NMS.
Topics: Adult; Chlorpromazine; Clopenthixol; Clozapine; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Procyclidine; Recurrence; Schizophrenia; Schizophrenic Psychology | 1991 |
Neuroleptic malignant syndrome (NMS): challenge with zuclopenthixol and follow-up--a case report.
Topics: Adult; Clopenthixol; Dyskinesia, Drug-Induced; Electroencephalography; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Psychiatric Status Rating Scales; Psychotic Disorders; Trifluoperazine | 1990 |
Zuclopenthixol-induced neuroleptic malignant syndrome at rechallenge and its extrapyramidal effects.
Topics: Adult; Clopenthixol; Female; Humans; Neuroleptic Malignant Syndrome; Psychotic Disorders; Thioxanthenes | 1989 |
A possible variant of the neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Humans; Male; Neuroleptic Malignant Syndrome; Thioxanthenes | 1987 |